MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$2,895,585
EPS
-$0.05
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Professional fees
711,169
924,580
General and administrative
231,404
339,377
Research and development
271,145
238,700
Share-based compensation
639,586
390,195
Total operating expenses
1,853,304
1,892,852
Net operating loss
-1,853,304
-1,892,852
Interest expense
1,177,999
1,760,025
Loss on conversion of debt
-
-331,546
Change in fair value of warrant liability
-79,447
121,476
Other income (expense)
56,271
12,668
Total other income (expense)
-1,042,281
-2,200,379
Net loss before income taxes
-2,895,585
-4,093,231
Income taxes
-
0
Net loss
-2,895,585
-4,093,231
Basic EPS
-0.05
-0.12
Diluted EPS
-0.05
-0.12
Basic Average Shares
59,416,539
33,952,418
Diluted Average Shares
59,416,539
33,952,418
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$2,895,585
Net loss before
income taxes
-$2,895,585
Net operating loss
-$1,853,304
Total other income
(expense)
-$1,042,281
Change in fair value of
warrant liability
-$79,447
Other income
(expense)
$56,271
Total operating
expenses
$1,853,304
Interest expense
$1,177,999
Professional fees
$711,169
Share-based compensation
$639,586
Research and development
$271,145
General and
administrative
$231,404
Buy us a coffee
Klotho Neurosciences, Inc. (KLTO)
Klotho Neurosciences, Inc. (KLTO)